- 09:01 AM Stock picking will become important in 2010: Morga...
- 09:01 AM Rupee opens at Rs 46.57 per dollar
- 09:00 AM MIAL to levy 10% on airline caterers' turnover fro...
- 09:00 AM Buy on any dip in Asia: ING Financial Markets
- 08:58 AM Nifty open interest PCR rises to 1.65 vs 1.57
- 08:57 AM IOC buys 4 mn bbls Jan Angolan crude; seeks more
- 08:57 AM Rising oil price would hurt economic rebound: IEA
- 08:57 AM Greenhouse gases reach record levels: UN agency
- 08:57 AM Bank mgmt, unions face off over pension scheme
- 08:41 AM BHEL looks positive: Astromoneyguru



Karvy Stock Broking has rated Ranbaxy Laboratories as a market performer with a target price of Rs 587 in its June 20, 2008 research report. "Ranbaxy has entered into agreements with Pfizer Inc to settle patent litigation worldwide involving Lipitor in US ( USD 8 billion) and 7 other countries (USD 2.5 billion). The settlement also involves Caduet USD 400 million (combination of Atorvastatin and Amlodipine)."
"We value the core business of the company at Rs 435 based on 25x CY 2009E basis while we value the FTF opportunity of Imitrex and Valacyclovir of Rs 8.4 in CY 2009E at 6x which translates in a Rs 50 per share value in CY 2009E. As the Nexium upside is a recurring business we value it at 25x and ascribe a value of Rs 65 to it. The NPV for the Lipitor and Caduet is Rs 37 and we ascribe that value. We arrive at a fair value of Rs 587 for the company and rate the company as Market Performer," says Karvy's research report.
Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
For further details click on attachment......
Attachments : Daily_20-06-08.pdf |
|
Stock Advice
|
|
|
Business
Business News | Economy | Earnings | BSE NSE Notices
General News
Current Affairs | Politics | World News | Sports | Entertainment
Corporate Strategy
Management | Advertising | Marketing | Legal
Personal Finance
Tax | Insurance | Credit Cards | Loans | Property | Retirement | Investment Help | Financial Planning | Fixed Income
Markets
Local Market | Global Market | Market Cues | Analysis | Expert & FII outlook | Brokerage Recomendation
Stocks
Stocks in News | Expert Advice | ADRs & GDRs | IPO
Mutual Funds
News | Advice | MF Analysis | Fund Managers Views
Lifestyle
Travel | Wellness | Technology | Auto| Books
-
Most Read
-
Most Viewed
- 10 Companies that FIIs love
- Experts see mkts at new highs, advise sectors

- Corrections in '10 to be more aggressive, violent: JPMorgan

- Trading in MF units to start in 15 days: SEBI

- Bollywood actress Shilpa Shetty marries Raj Kundra
- 10 companies that MF managers love
- Mahindra arm to bid for $3.5 bn defence deals
- Ignore Buffett, gold`s time has come
- Stock picking will become important in 2010: Morgan Stanley
Source: CNBC-TV18
- Rupee opens at Rs 46.57 per dollar
Source: CNBC-TV18
- Buy on any dip in Asia: ING Financial Markets
Source: CNBC-TV18
- Nifty open interest PCR rises to 1.65 vs 1.57
Source: CNBC-TV18
- China`s Haitong Securities buys Hong Kong rival
Source: ft.com
- KSIDC in pact with FACT for trade centre
Source: Business Line
- GIC Re may have to pay Rs100cr for IOC's Jaipur fire claims
Source: Business Line
- Co-operative dairies seek restraint on oil-meal exports
Source: Business Line






















